HomeUBX • NASDAQ
add
Unity Biotechnology Inc
Previous close
$1.47
Day range
$1.46 - $1.49
Year range
$1.46 - $3.82
Market cap
24.84M USD
Avg Volume
62.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.88M | -18.72% |
Net income | -1.50M | -216.21% |
Net profit margin | — | — |
Earnings per share | -0.28 | 72.00% |
EBITDA | -5.39M | 53.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 43.20M | -54.43% |
Total assets | 65.69M | -47.17% |
Total liabilities | 37.29M | -45.37% |
Total equity | 28.40M | — |
Shares outstanding | 16.79M | — |
Price to book | 0.87 | — |
Return on assets | -20.81% | — |
Return on capital | -23.53% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.50M | -216.21% |
Cash from operations | -7.58M | 35.54% |
Cash from investing | 15.11M | 8,013.09% |
Cash from financing | 4.39M | 182.73% |
Net change in cash | 11.93M | 214.79% |
Free cash flow | -3.23M | -5.63% |
About
Unity Biotechnology is a publicly traded American biotechnology company that develops drugs that target senescent cells. Wikipedia
Founded
2011
Headquarters
Website
Employees
19